A modeling framework for evaluation and comparison of trigger strategies for switching from minipool to individual-donation testing for West Nile virus

Transfusion

Volumn 49, Issue 6, 2009, Pages 1151-1159

  Biggerstaff, Brad J ^a   Petersen, Lyle R ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY;

ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED STUDY; PREVALENCE; SCREENING TEST; SIMULATION; STATISTICAL MODEL; VIREMIA; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

ANTIBODIES, VIRAL; BLOOD DONORS; HUMANS; RNA, VIRAL; WEST NILE VIRUS;

EID: 66549109457     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02112.x     Document Type: Article

References (11)

1. Pealer LN, Marfin AA, Petersen LR, Lanciotti RS, Page PL, Stramer SL, Stobierski MG, Signs K, Newman B, Kapoor H, Goodman JL, Chamberland ME West Nile Virus Transmission Investigation Team. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003 349 : 1236 45.
2. Busch MP, Tobler LH, Saldanha J, Caglioti S, Shyamala V, Linnen JM, Gallarda J, Phelps B, Smith RI, Drebot M, Kleinman SH. Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003. Transfusion 2005 45 : 492 9.
3. Busch MP, Caglioti S, Robertson EF, McAuley JD, Tobler LH, Kamel H, Linnen JM, Shyamala V, Tomasulo P, Kleinman SH. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. N Engl J Med 2005 353 : 460 7.
4. Stramer SL, Fang CT, Foster GA, Wagner AG, Brodsky JP, Dodd RY. West Nile virus among blood donors in the United States, 2003 and 2004. N Engl J Med 2005 353 : 451 9.
5. Centers for Disease Control and Prevention. West Nile virus transmission through blood transfusion - South Dakota, 2006. MMWR Morb Mortal Wkly Rep 2007 56 : 76 9.
6. Custer B, Tomasulo PA, Murphy EL, Caglioti S, Harpool D, McEvoy P, Busch MP. Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making. Transfusion 2004 44 : 1547 54.
7. Centers for Disease Control and Prevention. West Nile virus activity - United States, 2006. MMWR Morb Mortal Wkly Rep 2007 56 : 556 9.
8. Biggerstaff BJ, Petersen LR. Estimated risk of transmission of the West Nile virus through blood transfusion in the US, 2002. Transfusion 2003 43 : 1007 17.
9. American Association of Blood Banks. West Nile virus. Bethesda (MD) : Blood Products Advisory Committee May 1-2, 2008. Available from: http://www.aabb.org/documents/News-and-Media/Statements/bpacstatement050108.pdf (accessed 2008 Jul 19).
10. Food and Drug Administration. Guidance for industry. Use of nucleic acid tests to reduce the risk of transmission of West Nile virus from donors of whole blood and blood components intended for transfusion and donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps). Draft guidance. Rockville (MD) : Food and Drug Administration 2008. Available from: http://www.fda.gov/cber/gdlns/natwnvhctp.htm (Accessed 2008 Jul 19).
11. Busch MP, Kleinman SH, Tobler LH, Kamel HT, Norris PJ, Walsh I, Matud JL, Prince HE, Lanciotti RS, Wright DJ, Linnen JM, Caglioti S. Virus and antibody dynamics in acute West Nile virus infection. The J Infect Dis 2008 198 : 984 93.